Post-translational modification of α-synuclein in Parkinson's disease von Barrett, Paul J, Timothy Greenamyre, J

Volltext

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives von Schapira, Anthony H V, Prof, Olanow, C Warren, Prof, Greenamyre, J Timothy, Prof, Bezard, Erwan, Prof

Volltext

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model von Sanders, Laurie H., Timothy Greenamyre, J.

Volltext

PCR Based Determination of Mitochondrial DNA Copy Number in Multiple Species von Rooney, John P., Ryde, Ian T., Sanders, Laurie H., Howlett, Evan. H., Colton, Meryl D., Germ, Kaylyn E., Mayer, Greg D., Greenamyre, J. Timothy, Meyer, Joel N.

Volltext

Toxin models of mitochondrial dysfunction in Parkinson's disease von Martinez, Terina N, Greenamyre, J Timothy

Volltext

Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models von Cannon, Jason R, Greenamyre, J. Timothy

Volltext

Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease von De Miranda, Briana R., Rocha, Emily M., Bai, Qing, El Ayadi, Amina, Hinkle, David, Burton, Edward A., Timothy Greenamyre, J.

Volltext

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases von Espay, Alberto J, Vizcarra, Joaquin A, Marsili, Luca, Lang, Anthony E, Simon, David K, Merola, Aristide, Josephs, Keith A, Fasano, Alfonso, Morgante, Francesca, Savica, Rodolfo, Greenamyre, J Timothy, Cambi, Franca, Yamasaki, Tritia R, Tanner, Caroline M, Gan-Or, Ziv, Litvan, Irene, Mata, Ignacio F, Zabetian, Cyrus P, Brundin, Patrik, Fernandez, Hubert H, Standaert, David G, Kauffman, Marcelo A, Schwarzschild, Michael A, Sardi, S Pablo, Sherer, Todd, Perry, George, Leverenz, James B

Volltext

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability von Hallacli, Erinc, Kayatekin, Can, Nazeen, Sumaiya, Wang, Xiou H., Sheinkopf, Zoe, Sathyakumar, Shubhangi, Sarkar, Souvarish, Jiang, Xin, Dong, Xianjun, Di Maio, Roberto, Wang, Wen, Keeney, Matthew T., Felsky, Daniel, Sandoe, Jackson, Vahdatshoar, Aazam, Udeshi, Namrata D., Mani, D.R., Carr, Steven A., Lindquist, Susan, De Jager, Philip L., Bartel, David P., Myers, Chad L., Greenamyre, J. Timothy, Feany, Mel B., Sunyaev, Shamil R., Chung, Chee Yeun, Khurana, Vikram

Volltext

A highly reproducible rotenone model of Parkinson's disease von Cannon, Jason R, Tapias, Victor, Na, Hye Mee, Honick, Anthony S, Drolet, Robert E, Greenamyre, J. Timothy

Volltext

LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease von Rocha, Emily M., De Miranda, Briana R., Castro, Sandra, Drolet, Robert, Hatcher, Nathan G., Yao, Lihang, Smith, Sean M., Keeney, Matthew T., Di Maio, Roberto, Kofler, Julia, Hastings, Teresa G., Greenamyre, J. Timothy

Volltext

LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction von Sanders, Laurie H, Laganière, Josée, Cooper, Oliver, Mak, Sally K, Vu, B. Joseph, Huang, Y. Anne, Paschon, David E, Vangipuram, Malini, Sundararajan, Ramya, Urnov, Fyodor D, Langston, J. William, Gregory, Philip D, Zhang, H. Steve, Greenamyre, J. Timothy, Isacson, Ole, Schüle, Birgitt

Volltext

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology von Drolet, Robert E, Cannon, Jason R, Montero, Laura, Greenamyre, J. Timothy

Volltext

Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats von Di Maio, Roberto, Cannon, Jason R, Greenamyre, J. Timothy

Volltext

The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease von De Miranda, Briana R., Castro, Sandra L., Rocha, Emily M., Bodle, Christopher R., Johnson, Katrina E., Greenamyre, J. Timothy

Volltext

LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants von Ilieva, Neda M., Hoffman, Eric K., Ghalib, Mohammed A., Greenamyre, J. Timothy, De Miranda, Briana R.

Volltext

Animal models of Parkinson's disease von Betarbet, Ranjita, Sherer, Todd B., Greenamyre, J. Timothy

Volltext

Phenothiazine normalizes the NADH/NAD + ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease von Tapias, Victor, McCoy, Jennifer L, Greenamyre, J Timothy

Volltext

NADPH oxidase 2 activity in Parkinson's disease von Keeney, Matthew T., Hoffman, Eric K., Farmer, Kyle, Bodle, Christopher R., Fazzari, Marco, Zharikov, Alevtina, Castro, Sandra L., Hu, Xiaoping, Mortimer, Amanda, Kofler, Julia K., Cifuentes-Pagano, Eugenia, Pagano, Patrick J., Burton, Edward A., Hastings, Teresa G., Greenamyre, J. Timothy, Di Maio, Roberto

Volltext

Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration von Zharikov, Alevtina, Bai, Qing, De Miranda, Briana R., Van Laar, Amber, Greenamyre, J. Timothy, Burton, Edward A.

Volltext